Stamenkovic I - Search Results

1

LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.

Keskin T, Bakaric A, Waszyk P, Boulay G, Torsello M, Cornaz-Buros S, Chevalier N, Geiser T, Martin P, Volorio A, Iyer S, Kulkarni A, Letovanec I, Cherix S, Cote GM, Choy E, Digklia A, Montemurro M, Chebib I, Nielsen PG, Carcaboso AM, Mora J, Renella R, Suvà ML, Fusco C, Provero P, Rivera MN, Riggi N, Stamenkovic I. Keskin T, et al. Among authors: stamenkovic i. Cell Rep. 2020 Mar 31;30(13):4567-4583.e5. doi: 10.1016/j.celrep.2019.12.053. Cell Rep. 2020. PMID: 32234488 Free article.

2

Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity.

Fiore E, Fusco C, Romero P, Stamenkovic I. Fiore E, et al. Among authors: stamenkovic i. Oncogene. 2002 Aug 8;21(34):5213-23. doi: 10.1038/sj.onc.1205684. Oncogene. 2002. PMID: 12149643

3

Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.

Riggi N, Cironi L, Provero P, Suvà ML, Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A, Stamenkovic I. Riggi N, et al. Among authors: stamenkovic i. Cancer Res. 2005 Dec 15;65(24):11459-68. doi: 10.1158/0008-5472.CAN-05-1696. Cancer Res. 2005. PMID: 16357154

4

Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.

Riggi N, Cironi L, Provero P, Suvà ML, Stehle JC, Baumer K, Guillou L, Stamenkovic I. Riggi N, et al. Among authors: stamenkovic i. Cancer Res. 2006 Jul 15;66(14):7016-23. doi: 10.1158/0008-5472.CAN-05-3979. Cancer Res. 2006. PMID: 16849546

5

A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival.

Bacac M, Provero P, Mayran N, Stehle JC, Fusco C, Stamenkovic I. Bacac M, et al. Among authors: stamenkovic i. PLoS One. 2006 Dec 20;1(1):e32. doi: 10.1371/journal.pone.0000032. PLoS One. 2006. PMID: 17183660 Free PMC article.

6

The Biology of Ewing sarcoma.

Riggi N, Stamenkovic I. Riggi N, et al. Among authors: stamenkovic i. Cancer Lett. 2007 Aug 28;254(1):1-10. doi: 10.1016/j.canlet.2006.12.009. Epub 2007 Jan 23. Cancer Lett. 2007. PMID: 17250957 Review.

7

Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.

Riggi N, Cironi L, Suvà ML, Stamenkovic I. Riggi N, et al. Among authors: stamenkovic i. J Pathol. 2007 Sep;213(1):4-20. doi: 10.1002/path.2209. J Pathol. 2007. PMID: 17691072 Review.

8

Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations.

Suvà ML, Cironi L, Riggi N, Stamenkovic I. Suvà ML, et al. Among authors: stamenkovic i. J Pathol. 2007 Oct;213(2):117-30. doi: 10.1002/path.2208. J Pathol. 2007. PMID: 17703479 Review.

9

EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.

Riggi N, Suvà ML, Suvà D, Cironi L, Provero P, Tercier S, Joseph JM, Stehle JC, Baumer K, Kindler V, Stamenkovic I. Riggi N, et al. Among authors: stamenkovic i. Cancer Res. 2008 Apr 1;68(7):2176-85. doi: 10.1158/0008-5472.CAN-07-1761. Cancer Res. 2008. PMID: 18381423 Free article.

10

IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.

Cironi L, Riggi N, Provero P, Wolf N, Suvà ML, Suvà D, Kindler V, Stamenkovic I. Cironi L, et al. Among authors: stamenkovic i. PLoS One. 2008 Jul 9;3(7):e2634. doi: 10.1371/journal.pone.0002634. PLoS One. 2008. PMID: 18648544 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters